LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 35.71%807.83M | 49.20%234.47M | 45.15%200.04M | 32.95%200.58M | 15.60%172.74M | -2.12%595.27M | -39.02%157.15M | -29.49%137.81M | 55.00%150.87M | 159.09%149.43M |
Operating revenue | 35.71%807.83M | 49.20%234.47M | 45.15%200.04M | 32.95%200.58M | 15.60%172.74M | -2.12%595.27M | -39.02%157.15M | -29.49%137.81M | 55.00%150.87M | 159.09%149.43M |
Cost of revenue | -10.59%1.73B | 8.11%443.25M | -12.17%412.54M | -15.37%470.36M | -19.13%404.8M | 17.62%1.94B | -33.36%410.02M | -4.62%469.72M | 90.12%555.81M | 103.49%500.52M |
Gross profit | 31.15%-923.11M | 17.44%-208.78M | 35.97%-212.51M | 33.38%-269.77M | 33.90%-232.06M | -29.18%-1.34B | 29.28%-252.86M | -11.74%-331.91M | -107.65%-404.93M | -86.46%-351.09M |
Operating expense | 19.79%2.08B | 8.30%524.18M | 32.70%557.96M | 15.35%497.42M | 24.91%497.86M | 11.45%1.73B | 23.42%484M | 7.67%420.45M | 18.40%431.22M | -2.61%398.57M |
Selling and administrative expenses | 13.01%900.95M | 1.19%243.89M | 23.14%233.59M | 6.32%210.25M | 26.34%213.23M | 8.53%797.24M | 41.06%241.03M | 7.33%189.69M | 20.72%197.75M | -24.37%168.77M |
Research and development costs | 25.55%1.18B | 15.35%280.29M | 40.57%324.37M | 23.00%287.17M | 23.86%284.63M | 14.06%937.01M | 9.80%242.98M | 7.95%230.76M | 16.52%233.47M | 23.50%229.8M |
Operating profit | 2.42%-3B | 0.53%-732.95M | -2.41%-770.46M | 8.25%-767.19M | 2.63%-729.92M | -18.54%-3.08B | 1.72%-736.87M | -9.43%-752.36M | -49.53%-836.15M | -25.46%-749.67M |
Net non-operating interest income expense | 0.41%180.1M | -6.58%47.55M | -33.77%41.54M | 45.82%47.88M | 31.11%43.13M | 585.62%179.36M | 137.90%50.9M | 274.25%62.72M | 867.53%32.84M | 526.18%32.9M |
Non-operating interest income | 4.28%213.03M | -1.46%57.83M | -24.29%50.02M | 38.02%54.55M | 26.56%50.63M | 259.92%204.27M | 99.10%58.68M | 171.05%66.06M | 1,257.78%39.53M | --40.01M |
Non-operating interest expense | 32.14%32.92M | 32.07%10.27M | 153.83%8.48M | -0.25%6.67M | 5.53%7.5M | -18.57%24.92M | -3.69%7.78M | -56.13%3.34M | -6.94%6.69M | -7.92%7.11M |
Other net income (expense) | 57.67%107.67M | 796.46%288.77M | -545.61%-263.07M | 91.20%75.85M | 109.76%6.11M | -94.60%68.29M | -87.39%32.21M | -58.08%59.04M | -88.44%39.67M | -111.95%-62.63M |
Gain on sale of security | 57.59%146.44M | 862.36%301.01M | -535.76%-262.83M | 140.07%101.15M | 117.45%7.12M | -92.59%92.93M | -87.78%31.28M | -56.96%60.32M | -87.42%42.13M | -107.80%-40.8M |
Special income (charges) | 17.28%-20.3M | --0 | 85.33%-76K | -1,220.37%-20.23M | --0 | ---24.55M | --0 | ---518K | ---1.53M | ---22.5M |
-Less:Restructuring and merger&acquisition | -17.28%20.3M | --0 | -85.33%76K | 1,220.37%20.23M | --0 | --24.55M | --0 | --518K | --1.53M | --22.5M |
Other non- operating income (expenses) | -20,421.11%-18.47M | -1,410.49%-12.24M | 79.69%-155K | -446.01%-5.07M | -250.97%-1.01M | -100.94%-90K | 355.19%934K | -214.74%-763K | -111.21%-928K | -30.23%667K |
Income before tax | 4.06%-2.71B | 39.33%-396.63M | -57.31%-991.99M | 15.74%-643.46M | 12.67%-680.67M | -116.81%-2.83B | -38.27%-653.75M | -18.99%-630.6M | -246.55%-763.65M | -862.66%-779.4M |
Income tax | 16.86%1.2M | 4,107.14%589K | 64.53%487K | -111.07%-65K | 45.74%188K | 170.71%1.03M | 108.70%14K | 98.66%296K | 763.24%587K | -60.06%129K |
Net income | 4.05%-2.71B | 39.24%-397.22M | -57.31%-992.48M | 15.81%-643.39M | 12.66%-680.86M | -116.83%-2.83B | -38.32%-653.77M | -19.01%-630.89M | -246.71%-764.23M | -858.99%-779.53M |
Net income continuous Operations | 4.05%-2.71B | 39.24%-397.22M | -57.31%-992.48M | 15.81%-643.39M | 12.66%-680.86M | -116.83%-2.83B | -38.32%-653.77M | -19.01%-630.89M | -246.71%-764.23M | -858.99%-779.53M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 4.05%-2.71B | 39.24%-397.22M | -57.31%-992.48M | 15.81%-643.39M | 12.66%-680.86M | -116.83%-2.83B | -38.32%-653.77M | -19.01%-630.89M | -246.71%-764.23M | -858.99%-779.53M |
Preferred stock dividends | 146.86M | 3.9M | ||||||||
Other preferred stock dividends | 347.61M | 239.69M | -42.84M | 0 | 0 | 0 | ||||
Net income attributable to common stockholders | -8.24%-3.06B | 2.58%-636.9M | -50.52%-949.64M | -3.40%-790.25M | 12.16%-684.76M | -116.83%-2.83B | -38.32%-653.77M | -19.01%-630.89M | -246.71%-764.23M | -858.99%-779.53M |
Basic earnings per share | 8.09%-1.25 | 24.14%-0.22 | -46.43%-0.41 | 15.00%-0.34 | 30.23%-0.3 | -74.36%-1.36 | -3.57%-0.29 | 12.50%-0.28 | -207.69%-0.4 | -760.00%-0.43 |
Diluted earnings per share | 8.09%-1.25 | 24.14%-0.22 | -46.43%-0.41 | 15.00%-0.34 | 30.23%-0.3 | 9.93%-1.36 | -3.57%-0.29 | 30.00%-0.28 | -21.21%-0.4 | -19.44%-0.43 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |